MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Increased vesicular monoamine transporter alleviate MPTP-induced impairment of neurogenesis

    K. Ma, G. Zhang, C. Han, X. Guo, Y. Xia, F. Wan, L. Kou, S. Yin, L. Liu, N. Xiong, J. Huang, T. Wang (Wuhan, China)

    Objective: In this study, we employed vesicular monoamine transporter 2–overexpressing mice (VMAT2-HI) to investigate the influence of increased vesicular storage of catacholamines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced…
  • 2019 International Congress

    Amimia in Parkinson’s Disease and its Relationship with Motor and Non-Motor Symptoms

    T. Maycas-Cepeda, C. Feliz-Feliz, L. Gomez-Vicente, R. García-Cobos, P. Lopez-Ruiz, R. Arroyo, PJ. García- Ruiz (Pozuelo de Alarcon, Spain)

    Objective: To asses the correlation of amimia (facial bradykinesia) with motor and non-motor symptoms (cognition and depression) in Parkinson´s disease (PD) patients. Background: Reduced facial expression,…
  • 2019 International Congress

    Identification of protein biomarker/s in CSF of Parkinson’s disease (PD) with cognitive impairment

    A. Naskar, A. Stezin, D. Gadara, S. Ahuja, V. Menon, N. Kamble, J. Saini, S. Hegde, U. Tatu, P. Pal, P. Alladi (Bangalore, India)

    Objective: i. To identify CSF protein biomarker/s in Parkinson's disease (PD) with cognitive impairment using LC-MS/MS proteomics. ii. To estimate the level of known AD…
  • 2019 International Congress

    Cognitive dysfunction can predict the body weight loss in patients with Parkinson’s disease

    RW. Ou, QQ. Wei, YB. Hou, XQ. Yuan, HF. Shang (Chengdu, China)

    Objective: The objective of this study was to examine the predictors of body weight loss in PD patients over years. Background: Early body weight loss…
  • 2019 International Congress

    Stimulation Frequency and Active Contact Location Influence Speech Problems in Parkinson’s Disease Patients with Bilateral Subthalamic Deep Brain Stimulation

    O. Phokaewvarangkul, K. Boonpang, R. Bhidayasiri (Bangkok, Thailand)

    Objective: This study aimed to identify the prevalence of speech problems including stuttering and hypophonia in patients with Parkinson’s disease (PD). Participants with or without…
  • 2019 International Congress

    Cognitive impairment in patients with Parkinson’s syndrome

    SH. Rakhimova, I. Usmonaliev, Y. Musaeva (Tashkent, Uzbekistan)

    Objective: Study the principle of cognitive impairment in Parkinson's syndrome (brain cerebral circulation disorder, backdrop of atherosclerosis). Background: Parkinsonism-neurologic syndrome is a disorderly degenerative disease…
  • 2019 International Congress

    [18F]THK-5351 PET Imaging in Progressive Supranuclear Palsy Concomitant with Cerebellar Ataxia in Early-stage: Clinicopathological Observations

    Y. Saitoh, K. Komatsu, E. Imabayashi, A. Moriya, H. Matsuda, Y. Saito, Y. Takahashi (Tokyo, Japan)

    Objective: To describe two cases of progressive supranuclear palsy (PSP) concomitant with cerebellar ataxia in early stage who underwent [18F]THK-5351 PET imaging and to investigate…
  • 2019 International Congress

    Examining level of hemoglobin in patients with parkinson’s disease and the role of hemoglobin level in the disease course

    SH. Shohimardonov, K. Daminova (Tashkent, Uzbekistan)

    Objective: 1. Is there a correlation between the concentration of hemoglobin in the blood and the development of Parkinson's disease? 2. Does the high level…
  • 2019 International Congress

    Can the Quantified Timed Up and Go (QTUG) device support decision making for patients undergoing Deep Brain Stimulation?

    J. Somerset, B. Hammersley, M. Bonello (Liverpool, United Kingdom)

    Objective: To increase the speed and objectivity of decision making for patients with Parkinson’s disease and gait impairments, undergoing deep brain stimulation (DBS), using the…
  • 2019 International Congress

    A study of factors causing psychiatric abnomalities in patients with Parkinson’s disease

    T. Syed, R. Borgohain (Hyderabad, India)

    Objective: To study the effect of disease duration , age of the patient, MOCA on neuropsychiatric manifestations in Fifty PD patients. Background: Neuro psychiatric symptoms…
  • « Previous Page
  • 1
  • …
  • 188
  • 189
  • 190
  • 191
  • 192
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley